Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Chang Gung Medical Journal
|
November 1, 2011
Biochemotherapy with carmustine, cisplatin, dacarbazine, tamoxifen and low-dose interleukin-2 for patients with metastatic malignant melanoma
Po-Jung Su, Jen-Shi Chen, Chuang-Chi Liaw, et al.
Biomedical Journal
|
May 17, 2026
External validation of MAGIC-D model in Taiwanese patients with advanced biliary tract cancer receiving durvalumab and chemotherapy
Chung-Hao Ku, Wen-Kuan Huang, Chun-Feng Wu, et al.
Scientific Reports
|
August 18, 2016
Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy
Po-Jung Su, Min-Hsien Wu, Hung-Ming Wang, et al.
Journal of Cancer
|
December 1, 2025
Validation of WHO 2017 Classification and Identification of Prognostic Factors in Patients with Pancreatic Neuroendocrine Neoplasms: A Real-World Experience in Taiwan
Wei-Pang Ho, Wen-Chi Chou, Chia-Hsun Hsieh, et al.
Journal of Pain and Symptom Management
|
July 17, 2013
Predictive factors for do-not-resuscitate designation among terminally ill cancer patients receiving care from a palliative care consultation service
Chen-Yi Kao, Hung-Ming Wang, Shu-Chuan Tang, et al.
The Prostate
|
July 1, 2021
Gonadotropin-releasing hormone antagonist associated with lower cardiovascular risk compared with gonadotropin-releasing hormone agonist in prostate cancer: A nationwide cohort and in vitro study
Dong-Yi Chen, Po-Jung Su, Lai-Chu See, et al.
International Journal of Cancer
|
November 8, 2022
Long-term use and risk of major adverse cardiac events: Comparing enzalutamide and abiraterone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer
Hung-Kai Chen, Po-Jung Su, Yan-Lin Wang, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Chang Gung Medical Journal
|
November 1, 2011
Biochemotherapy with carmustine, cisplatin, dacarbazine, tamoxifen and low-dose interleukin-2 for patients with metastatic malignant melanoma
Po-Jung Su, Jen-Shi Chen, Chuang-Chi Liaw, et al.
Biomedical Journal
|
May 17, 2026
External validation of MAGIC-D model in Taiwanese patients with advanced biliary tract cancer receiving durvalumab and chemotherapy
Chung-Hao Ku, Wen-Kuan Huang, Chun-Feng Wu, et al.
Scientific Reports
|
August 18, 2016
Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy
Po-Jung Su, Min-Hsien Wu, Hung-Ming Wang, et al.
Journal of Cancer
|
December 1, 2025
Validation of WHO 2017 Classification and Identification of Prognostic Factors in Patients with Pancreatic Neuroendocrine Neoplasms: A Real-World Experience in Taiwan
Wei-Pang Ho, Wen-Chi Chou, Chia-Hsun Hsieh, et al.
Journal of Pain and Symptom Management
|
July 17, 2013
Predictive factors for do-not-resuscitate designation among terminally ill cancer patients receiving care from a palliative care consultation service
Chen-Yi Kao, Hung-Ming Wang, Shu-Chuan Tang, et al.
The Prostate
|
July 1, 2021
Gonadotropin-releasing hormone antagonist associated with lower cardiovascular risk compared with gonadotropin-releasing hormone agonist in prostate cancer: A nationwide cohort and in vitro study
Dong-Yi Chen, Po-Jung Su, Lai-Chu See, et al.
International Journal of Cancer
|
November 8, 2022
Long-term use and risk of major adverse cardiac events: Comparing enzalutamide and abiraterone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer
Hung-Kai Chen, Po-Jung Su, Yan-Lin Wang, et al.
Page
of 5